Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis
出版年份 2019 全文链接
标题
Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis
作者
关键词
-
出版物
World Journal of Surgical Oncology
Volume 17, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-10-22
DOI
10.1186/s12957-019-1706-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II—The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer
- (2018) Esmeralda Celia Marginean et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I—Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications
- (2018) Esmeralda Celia Marginean et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Prognostic significance of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer
- (2018) Hanumant Chouhan et al. Asia-Pacific Journal of Clinical Oncology
- Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival
- (2017) Pan Li et al. PLoS One
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX)
- (2016) Jeong Eun Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
- (2016) Chang Gon Kim et al. BRITISH JOURNAL OF CANCER
- Prognostic and predictive value of extendedRASmutation and mismatch repair status in stage III colorectal cancer
- (2016) Yusuke Sasaki et al. CANCER SCIENCE
- Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer
- (2016) H.M. Mohan et al. EJSO
- PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes
- (2016) Matthew W Rosenbaum et al. MODERN PATHOLOGY
- Prognostic Effect ofBRAFandKRASMutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab
- (2016) Julien Taieb et al. JAMA Oncology
- Mismatch repair status and synchronous metastases in colorectal cancer: A nationwide cohort study
- (2015) Andreas Nordholm-Carstensen et al. INTERNATIONAL JOURNAL OF CANCER
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer
- (2015) Junli Ma et al. TUMOR BIOLOGY
- Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial
- (2014) D. Klingbiel et al. ANNALS OF ONCOLOGY
- Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
- (2014) S. Venderbosch et al. CLINICAL CANCER RESEARCH
- Ephrin B2 Receptor and Microsatellite Status in Lymph Node-Positive Colon Cancer Survival
- (2014) Arik Drucker et al. Translational Oncology
- Prognostic value of microsatellite instability and p53 expression in metastatic colorectal cancer treated with oxaliplatin and fluoropyrimidine-based chemotherapy
- (2014) S. Nöpel-Dünnebacke et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study
- (2013) Se Hyun Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy
- (2013) Frank A. Sinicrope et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncologic Outcomes after Adjuvant Chemotherapy Using FOLFOX in MSI-H Sporadic Stage III Colon Cancer
- (2013) Seung Yeop Oh et al. WORLD JOURNAL OF SURGERY
- Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
- (2011) Ben Tran et al. CANCER
- Association between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancer
- (2011) Jeong Eun Kim et al. CANCER SCIENCE
- Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
- (2011) A. Zaanan et al. CLINICAL CANCER RESEARCH
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
- (2011) F. A. Sinicrope et al. JNCI-Journal of the National Cancer Institute
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin
- (2009) A. Zaanan et al. ANNALS OF ONCOLOGY
- Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
- (2009) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started